This is a consensus study report of the National Academies of Sciences, Engineering, and Medicine put together by a committee of experts in the field. It summarizes the evidence on medications for opioid use disorder (MOUD), discusses the use of and evidence for these medications in different populations and settings, and identifies barriers to implementing MOUD. 

This report from SAMHSA provides an updated overview of three Food and Drug Administration-approved medications for opioid use disorder treatment—methadone, naltrexone, and buprenorphine—and other strategies and services needed to support people in treatment. It is targeted towards healthcare and addiction professionals, policymakers, patients, and their families. 

This is an academic paper that describes the collaboration between a multidisciplinary team of university, state and federal agency, and community experts to create a unified database linking controlled substance prescribing, overdose, and treatment for opioid use disorder in Connecticut that can better-inform interventions across the state. 

This report examines the current federal regulatory and legal landscape around the provision of and access to methadone for the treatment of OUD. It explores potential policy changes to address federal, state, and local barriers to the provision of methadone treatment and consider opportunities for implementing office-based methadone treatment.

This is a report from the Alliance for Addiction Payment Reform, a group advocating for employing a chronic disease model of treatment for substance use disorder, that gives an overview of the availability of digital technology options to improve treatment outcomes, such as telehealth, digital apps, virtual recovery supports, and wearables and monitoring devices. 

This is an academic paper that is a quality improvement study in which the authors investigated whether medications used to treat opioid use disorder such as buprenorphine can be effectively provided to individuals living in rural areas via telemedicine in a mobile treatment unit. Findings suggest that the combination of telemedicine and mobile services is a unique approach to extend access to medications for opioid use disorder to rural areas 

This is a guide from the National Association of County and City Health Officials (NACCHO) which provides strategies for rural communities to mobilize community partnerships for public health programming, including local examples and lessons learned. 

This is a report which outlines a model state legislation to create an opioid litigation fund and council. The prospective fund would ensure that money allocated to states through opioid litigation settlements and judgements solely be used to address the opioid crisis. 

This is a report from the U.S. Department of Health and Human Services that reviews strategies to increase retention in treatment for opioid use disorder, which research has shown to significantly improve long-term outcomes. This document provides a literature review, summarizes stakeholder interviews, and highlights five successful existing models. 

This is a toolkit from the Centre of Excellence for Women's Health that is tailored for service providers and health system planners who offer services to, or design services with, pregnant individuals and new mothers who use substances, with an emphasis on addressing stigma. The toolkit includes many useful tools and fact sheets. 

This is an abstract of an academic paper that describes the process and results of convening a multidisciplinary team in Rhode Island to address the opioid crisis with the goals of identifying gaps in policies and programming and developing recommendations to prevent future deaths.

This is a website that offers states resources on best practices, innovative policies, and emerging issues related to opioid use disorder treatment, with a particular focus on telehealth, expanding harm reduction services, and serving marginalized populations during the coronavirus pandemic.